Re: PNAS - jbuffet
|
10
|
Resverlogix Corp.
|
Jan 02, 2021 04:27PM
|
Re: PNAS - jbuffet
|
7
|
Resverlogix Corp.
|
Jan 02, 2021 05:50PM
|
Re: PNAS
|
9
|
Resverlogix Corp.
|
Jan 02, 2021 08:33AM
|
Re: PNAS
|
5
|
Resverlogix Corp.
|
Jan 02, 2021 03:43PM
|
Re: PNAS
|
9
|
Resverlogix Corp.
|
Jan 02, 2021 03:50PM
|
Re: PM question
|
1
|
Resverlogix Corp.
|
May 31, 2019 10:10AM
|
Re: plenty of scenarios being put out there...
|
3
|
Zenith Epigenetics
|
Dec 11, 2015 11:09AM
|
Re: plenty of scenarios being put out there...
|
2
|
Zenith Epigenetics
|
Dec 11, 2015 12:01PM
|
Re: Please keep post respectful
|
7
|
Resverlogix Corp.
|
Jan 23, 2021 11:05AM
|
Re: Please add US BIOAF listing to the Stock Quote Sidebar
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 20, 2016 11:28AM
|
Re: Playing with Number of patient years and RRR%
|
3
|
Resverlogix Corp.
|
Apr 01, 2019 11:24AM
|
Re: Placebo rate of BETonMACE
|
3
|
Resverlogix Corp.
|
Nov 01, 2019 04:28PM
|
Re: Placebo rate now that 250 MACE has been reached
|
3
|
Resverlogix Corp.
|
Jun 11, 2019 09:53AM
|
Re: Placebo rate for 2 sub groups
|
5
|
Resverlogix Corp.
|
Mar 12, 2019 09:59AM
|
Re: Placebo or Standard of Care
|
6
|
Resverlogix Corp.
|
Nov 02, 2019 11:37AM
|
Re: Piper's 17 biopharma surprises for 17
|
7
|
Resverlogix Corp.
|
Dec 22, 2016 10:35AM
|
Re: Phase 4 - Appraently for drugs already approved for marketing.....
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 11:06PM
|
Re: Phase 4 - Appraently for drugs already approved for marketing.....
|
2
|
Resverlogix Corp.
|
Jan 28, 2019 07:52AM
|
Re: Phase 3 - Fall Start
|
3
|
Resverlogix Corp.
|
Jun 22, 2015 11:26AM
|
Re: Phase 3 - Fall Start
|
2
|
Resverlogix Corp.
|
Jun 22, 2015 11:49AM
|